Apre | search
Click here to view Apre news from 60+ newspapers.
Bookmark or Share- Aprea Therapeutics, Inc. (APRE) - Yahoo FinanceFind the latest Aprea Therapeutics, Inc. (APRE) stock quote, history, news and other vital information to help you with your stock trading and investing.
- Buy Rating on Aprea Therapeutics: Outshining ... - Markets InsiderAPRE’s price has also changed moderately for the past six months – from $3.650 to $4.020, which is a 10.14% increase. See the top stocks recommended by analysts >>
- APRE Stock Price Quote | MorningstarSee the latest Aprea Therapeutics Inc stock price (APRE:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
- Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its ...The Company’s lead program is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. Aprea has received FDA clearance on an IND to begin clinical studies of APR-1051, its oral, small molecule WEE1 inhibitor.
- Aprea Therapeutics, Inc. (APRE) - Stock AnalysisGet a real-time Aprea Therapeutics, Inc. (APRE) stock price quote with breaking news, financials, statistics, charts and more.
More
